Seltzer, E., Goldberg, L., Krause, D., Simoneau, D., & Boudry, E. (2008). Dalbavancin safety in the phase 2/3 clinical development program. BioMed Central.
Citação norma ChicagoSeltzer, E., L. Goldberg, D. Krause, D. Simoneau, and E. Boudry. Dalbavancin Safety in the Phase 2/3 Clinical Development Program. BioMed Central, 2008.
ציטוט MLASeltzer, E., et al. Dalbavancin Safety in the Phase 2/3 Clinical Development Program. BioMed Central, 2008.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.